Skip to main content

Palihapitiya Chamath's Form 4 filing

Prokidney Corp. (PROK) · filed Nov 17, 2023

Accession no.
0001104659-23-119652
Filed
Nov 17, 2023, 9:00 PM ET
Trade date
Nov 15-17, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market sales total $987.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Palihapitiya ChamathCIK 000171545010% Owner
SC Master Holdings, LLCCIK 000185102410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 15, 2023Class A ordinary sharesSSaleDisposed−282,300$1.49F1−$420,147.095,653,867Indirect
Nov 16, 2023Class A ordinary sharesSSaleDisposed−212,100$1.22F3−$259,398.35,441,767Indirect
Nov 17, 2023Class A ordinary sharesSSaleDisposed−258,400$1.19F4−$308,400.45,183,367Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.3400 to $1.7950. The reporting person undertakes to provide ProKidney Corp. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.1700 to $1.4100. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.1200 to $1.2550. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)